Just Released
|
||
As the Ebola outbreak in the DRC continues, new KFF explainer
examines the status of the response and the limited U.S. role to date
The ongoing Ebola outbreak in the Democratic
Republic of Congo (DRC), recently declared a “public health emergency of
international concern” by the WHO Director-General, is now second only to the
West Africa outbreak of 2014-2015 in terms of number of cases and deaths. A new KFF explainer reviews the history of the outbreak
in the DRC, which U.S. agencies are involved, how U.S. personnel are
assisting, global response activities, and the role of vaccination in
controlling the outbreak.
U.S. engagement has been limited compared to the
2014-2015 West Africa outbreak, where the U.S played a leading role and
mobilized an unprecedented amount of funding and personnel. The U.S. has
chosen a more limited role in this outbreak due to security concerns as well
as improvements in global capacity to respond to Ebola. So far, the U.S. has
contributed $136 million for the response.
The explainer also discusses how the U.S.
government might change its approach and engagement in the DRC going forward,
such as by providing additional funding or allowing U.S. government personnel
to work directly in the outbreak zone.
Filling the need for trusted information on
national health issues, the Kaiser Family Foundation is a
nonprofit organization based in San Francisco, California.
|
||
|
||
To be a Medicare Agent's source of information on topics affecting the agent and their business, and most importantly, their clientele, is the intention of this site. Sourced from various means rooted in the health insurance industry - insurance carriers, governmental agencies, and industry news agencies, this is aimed as a resource of varying viewpoints to spark critical thought and discussion. We welcome your contributions.
Tuesday, July 30, 2019
As the Ebola outbreak in the DRC continues, new KFF explainer examines the status of the response and the limited U.S. role to date
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment